These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35757906)

  • 1. Crossroads between copper ions and amyloid formation in Parkinson's disease.
    Wittung-Stafshede P
    Essays Biochem; 2022 Dec; 66(7):977-986. PubMed ID: 35757906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between Copper Chaperone Atox1 and Parkinson's Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells.
    Horvath I; Blockhuys S; Šulskis D; Holgersson S; Kumar R; Burmann BM; Wittung-Stafshede P
    ACS Chem Neurosci; 2019 Nov; 10(11):4659-4668. PubMed ID: 31600047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper ion incorporation in α-synuclein amyloids.
    Walke G; Kumar R; Wittung-Stafshede P
    Protein Sci; 2024 Apr; 33(4):e4956. PubMed ID: 38511511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.
    Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Cu
    Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
    Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper chaperone blocks amyloid formation via ternary complex.
    Horvath I; Werner T; Kumar R; Wittung-Stafshede P
    Q Rev Biophys; 2018 Jan; 51():e6. PubMed ID: 30912493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein.
    Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO
    Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease.
    Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation.
    Ranjan P; Ghosh D; Yarramala DS; Das S; Maji SK; Kumar A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):365-374. PubMed ID: 27916677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro.
    Zhang X; Walke GR; Horvath I; Kumar R; Blockhuys S; Holgersson S; Walton PH; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2206905119. PubMed ID: 36067318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells.
    Greco M; Spinelli CC; De Riccardis L; Buccolieri A; Di Giulio S; Musarò D; Pagano C; Manno D; Maffia M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A revised picture of the Cu(II)-α-synuclein complex: the role of N-terminal acetylation.
    Moriarty GM; Minetti CA; Remeta DP; Baum J
    Biochemistry; 2014 May; 53(17):2815-7. PubMed ID: 24739028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the copper binding features of alpha and beta synucleins.
    Rodríguez EE; Ríos A; Trujano-Ortiz LG; Villegas A; Castañeda-Hernández G; Fernández CO; González FJ; Quintanar L
    J Inorg Biochem; 2022 Apr; 229():111715. PubMed ID: 35074552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?
    De Ricco R; Valensin D; Dell'Acqua S; Casella L; Hureau C; Faller P
    Chembiochem; 2015 Nov; 16(16):2319-28. PubMed ID: 26338312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discerning Modulation of α-Synuclein Amyloid Assembly by α-Crystallin.
    Pippal B; Chaudhuri P; Rani K; Yadav JK; Jain N
    ACS Chem Neurosci; 2023 May; 14(9):1659-1671. PubMed ID: 37057966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
    Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
    J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination and redox properties of copper interaction with α-synuclein.
    Valensin D; Dell'Acqua S; Kozlowski H; Casella L
    J Inorg Biochem; 2016 Oct; 163():292-300. PubMed ID: 27112900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
    Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.